Category Archives: Flibanserin

A little bit more on the medicalisation of sex

TweetIt’s been a while since I’ve written about medicalisation. Which seems as good an excuse as any to revisit this issue and reflect on some of the developments in this area in healthcare, therapy and media. A few months ago I took part in the 41st Maudsley Debate entitled ‘Love is a Drug’. Ben Goldacre [...]
Also posted in Activism and Open Access, Bad science, Commercialisation, Erectile Dysfunction, Evidence based, Female Sexual Dysfunction, Gender, Intrinsa, Journalism, Medicalisation, Orgasm, Premature Ejaculation | Comments closed

The best and worst sex (and science) stories of 2010

TweetThis year seems to have just flown by, and what a busy one it was for research and stories about sex. From philandering footballers to STI statistics we certainly got to hear a lot about relationships. Here are some of the main stories I think made up the year in media, sex and science. The [...]
Also posted in Commercialisation, Critical appraisal, Female Sexual Dysfunction, G spot, Health/care, Human rights/law, Politics, Pornography | Comments closed

“Women with low libidos ‘have different brains’”

Tweet * If you ever wanted to see how the media simultaneously loves and destroys stories on sex and science, this week we had a classic example of truly bad sex coverage. All based on a conference presentation that suggested low libido in women could be detected through brain scanning. I’ll move on to the [...]
Also posted in Activism and Open Access, Bad science, Female Sexual Dysfunction | Comments closed

FDA advisory panel rejects Flibanserin

TweetLast Friday drug company Boehringer Ingelheim presented evidence to the FDA’s advisory panel on their drug Flibanserin. This product, designed to tackle Hypoactive Sexual Desire Disorder (HSDD) in women had already been given plenty of media coverage focusing on ‘Pink Viagra’, and raised concern from scientists, healthcare staff, therapists and activists. You can see a [...]
Also posted in Activism and Open Access, Commercialisation, Female Sexual Dysfunction | Comments closed

Is low sexual desire in women a disease? No it’s not. But drug company are seeking FDA approval for a drug to ‘cure’ women nonetheless

TweetOn June 18th pharmaceutical company Boehringer Ingelheim will be seeking approval from the Food and Drug Administration (FDA) for their drug Flibanserin (which may be traded under the names of Ectris and/or Girosa). This is an antidepressant style drug which Boehringer Ingelheim claim is a treatment for low/lack of sexual desire in women (aka Hypoactive [...]
Also posted in Activism and Open Access, Female Sexual Dysfunction, Intrinsa, Medicalisation | Comments closed

Am I bovvered…about not desiring sex?

A drug company has launched a new study and patient registry to measure female sexual problems. Using a five question quick checklist you can now be diagnosed as dysfunctional.
Also posted in Female Sexual Dysfunction, Sexual dysfunction, Surveys/questionnaires | Comments closed

More about Flibanserin

You'll remember a couple of weeks ago there was a lot of media hype around the development of a new drug - Flibanserin- aimed at tackling 'Hypoactive Sexual Desire Disorder' in women. There's been a few developments in the media coverage of the drug over the past fortnight so I thought it was a good time to catch up with some of the issues addressed.
Also posted in Desire, Female Sexual Dysfunction, Medicalisation | Comments closed

Celebrating this blog’s fifth birthday!

It's five years since I started blogging. So please put on a party hat, help yourself to some nibbles, and join me for a look back over the past half decade.
Also posted in 'sexpert', Academia, Activism and Open Access, Agony Aunt, Alternative relationships, Bad science, BDSM, Big Brother, Celebrity, Clitoris, Commercialisation, Contraception, Critical appraisal, Dating, Desire, Disability, Erectile Dysfunction, Ethics, Expert(s), Female Sexual Dysfunction, Formula, Journalism, Magazines, Newspapers, Orgasm, Penis, Petra, Politics, PR, Predictions, Premature Ejaculation, self help, Sex education, Sex positive, Sex tips/advice, Sexual dysfunction, Sexually transmitted infection(s), Surveys/questionnaires, Vagina, Viagra | Comments closed

New trials of female sexual dysfunction drug (Flibanserin) will be reported this week

Here's the back plot to this latest drug for female sexual dysfunction and questions you should be asking about Flibanserin.
Also posted in Activism and Open Access, Desire, Female Sexual Dysfunction, Intercourse, Intrinsa, Journalism, Medicalisation, Orgasm, PT141, RCTs, Research, Sexual dysfunction, Viagra | Comments closed